DNLI — DENALI THERAPEUTICS INC

Ownership history in Engineers Gate Manager LP  ·  18 quarters on record

This page tracks every 13F SEC filing in which Engineers Gate Manager LP reported a position in DENALI THERAPEUTICS INC (DNLI). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.05% (2023 Q1)
Avg. % of fund
0.02%
First filed
2019 Q4
Last filed
2025 Q3
Quarters held
18
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 69,216 -46,885 -40.4% 0.01% $1.0M $14.52
2025 Q2 ADDED 116,101 +98,903 +575.1% 0.02% $1.6M $13.99
2025 Q1 REDUCED 17,198 -36,160 -67.8% 0.00% $234K $13.60
2024 Q4 ADDED 53,358 +42,228 +379.4% 0.02% $1.1M $20.38
14 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    DNLI price (monthly, adj. close)

Other funds also holding DNLI

As of 2025 Q4 — sorted by position size

Crestline Management, LP 3Y 7Y 87.02% Lynx1 Capital Management LP 3Y 5.81% Casdin Capital, LLC 3Y 7Y 1.89% Palo Alto Investors LP 3Y 7Y 1.47% DAFNA Capital Management LLC 3Y 7Y 1.22% STEMPOINT CAPITAL LP 1.19% Monashee Investment Management LLC 3Y 7Y 0.85% Siren, L.L.C. 0.69% MASTERS CAPITAL MANAGEMENT LLC 3Y 7Y 0.67% PSP Research LLC 0.46%
← Back to Engineers Gate Manager LP Holdings